Hospital readmissions in patients with inflammatory bowel disease.
Am J Gastroenterol
; 108(7): 1024-32, 2013 Jul.
Article
en En
| MEDLINE
| ID: mdl-23820989
ABSTRACT
OBJECTIVES:
We aimed to identify the frequency and costs of, and the disease predictors and inpatient process issues that may predispose to, 30-day readmission for an inflammatory bowel disease (IBD) patient.METHODS:
IBD patients admitted to an inpatient gastroenterology service were followed for a time-to-readmission analysis assessing factors associated with readmission within 30 days.RESULTS:
Index admissions were more costly among those readmitted than among those not readmitted. Patients admitted with evidence of increased inflammation, infection, or obstruction or for dehydration or pain control had a higher risk of readmission. Patients treated with opioid analgesia during index admission were no less likely to be readmitted, and there was a 2.2-fold increase in readmissions when patients were discharged with no opioid analgesia. Scheduling variability and outpatient follow-up compliance were associated with readmission.CONCLUSIONS:
Predicting readmission is complex. A predictive model developed to be used at discharge yielded an area under the curve of 0.757.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Readmisión del Paciente
/
Enfermedades Inflamatorias del Intestino
Tipo de estudio:
Etiology_studies
/
Prognostic_studies
Límite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Am J Gastroenterol
Año:
2013
Tipo del documento:
Article
País de afiliación:
Estados Unidos